GlassScriptPhysician profile
Cody Sanders
NPI 1952968125
$1,258.40
in general payments reported to CMS, 2019-2025
17 companies · $981 in 2025
The $981 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $277 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $338.17 | 2024-2025 | |
| Abbvie INC. | $258.91 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $185.68 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $92.43 | 2025 | Austedo Xr |
| Argenx US, INC. | $81.00 | 2024-2025 | Vyvgart |
| Alexion Pharmaceuticals, INC. | $51.17 | 2025 | Ultomiris |
| Janssen Biotech, INC. | $42.27 | 2025 | |
| Ucb, INC. | $37.32 | 2024-2025 | Nayzilam, Briviact |
| Lundbeck LLC | $32.00 | 2024-2025 | Rexulti |
| Genzyme Corporation | $25.63 | 2025 | |
| Medtronic, INC. | $21.12 | 2024 | Percept PC Brainsense |
| Neurelis, INC. | $18.99 | 2025 | Valtoco |
| Acadia Pharmaceuticals INC | $17.35 | 2025 | Nuplazid |
| Eisai INC. | $16.47 | 2024 | |
| Emd Serono, INC. | $15.79 | 2025 | Mavenclad |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $13.53 | 2024 | Ingrezza |
| Aucta Pharmaceuticals, INC. | $10.57 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.